T-20: 5-drug combination trial for heavily treated NNRTI-naive patients now recruiting.
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007279:Injections, Subcutaneous; D018579:Patient Selection; D010446:Peptide Fragments / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States
D019380:Anti-HIV Agents; D010446:Peptide Fragments